From chemo-prevention to epigenetic regulation: The role of isothiocyanates in skin cancer prevention

Melina Mitsiogianni, Tom Amery, Rodrigo Franco-Cruz, Vasilis Zoumpourlis, Aglaia Pappa, Mihalis I. Panayiotidis

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Skin cancer incidence is rapidly growing over the last decades and is generally divided into malignant melanoma and non-melanoma (NMSC) with the latter being subdivided into squamous (SCC) and basal cell carcinoma (BCC). Among them, melanoma is the most aggressive type with high mortality rates. On the other hand, aberrant gene expression is a critical step towards malignant transformation. To this end, epigenetic modifications like changes in DNA methylation patterns and miRNA expression profile as well as histone modifications are all capable of inducing an altered gene expression profile involved in various cellular cascades including cell cycle, proliferation and apoptosis. In general, there is an interest about the beneficiary effect of various phytochemicals in the prevention and treatment of skin malignancies. Among them, glucosinolates are an important type of compounds, abundant in cruciferous vegetables, which are hydrolysed by an endogenous enzyme called myrosinase to a range of bioactive compounds including isothiocyanates (ITCs). These are the major biologically active products capable of mediating the anti-cancer effect of cruciferous vegetables. Their chemo-preventive action is mainly attributed to a plurality of anti-cancer properties including regulation of the epigenetic machinery. Current evidence supports the view that ITCs are potent compounds in interacting with the epigenome in order to restore the normal epigenetic landscape in malignant cells. This review article summarizes the current state of knowledge on the epigenetic modifications that lead to malignant transformation and the role of ITCs with respect to their ability to restore the epigenetic landscape that contributes to skin carcinogenesis.

Original languageEnglish (US)
Pages (from-to)187-201
Number of pages15
JournalPharmacology and Therapeutics
Volume190
DOIs
StatePublished - Oct 2018

Fingerprint

Isothiocyanates
Skin Neoplasms
Epigenomics
Vegetables
Melanoma
Histone Code
Glucosinolates
Neoplasms
Skin
Basal Cell Carcinoma
Phytochemicals
DNA Methylation
MicroRNAs
Transcriptome
Squamous Cell Carcinoma
Cell Cycle
Carcinogenesis
Cell Proliferation
Apoptosis
Gene Expression

Keywords

  • Basal cell carcinoma
  • Chemoprevention
  • Epigenetic regulation
  • Isothiocyanates
  • Melanoma
  • Non-melanoma skin cancer
  • Skin cancer
  • Squamous cell carcinoma
  • Sulforaphane

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

From chemo-prevention to epigenetic regulation : The role of isothiocyanates in skin cancer prevention. / Mitsiogianni, Melina; Amery, Tom; Franco-Cruz, Rodrigo; Zoumpourlis, Vasilis; Pappa, Aglaia; Panayiotidis, Mihalis I.

In: Pharmacology and Therapeutics, Vol. 190, 10.2018, p. 187-201.

Research output: Contribution to journalReview article

Mitsiogianni, Melina ; Amery, Tom ; Franco-Cruz, Rodrigo ; Zoumpourlis, Vasilis ; Pappa, Aglaia ; Panayiotidis, Mihalis I. / From chemo-prevention to epigenetic regulation : The role of isothiocyanates in skin cancer prevention. In: Pharmacology and Therapeutics. 2018 ; Vol. 190. pp. 187-201.
@article{a44e0cf3da6245cf8b9a25fffdcbe037,
title = "From chemo-prevention to epigenetic regulation: The role of isothiocyanates in skin cancer prevention",
abstract = "Skin cancer incidence is rapidly growing over the last decades and is generally divided into malignant melanoma and non-melanoma (NMSC) with the latter being subdivided into squamous (SCC) and basal cell carcinoma (BCC). Among them, melanoma is the most aggressive type with high mortality rates. On the other hand, aberrant gene expression is a critical step towards malignant transformation. To this end, epigenetic modifications like changes in DNA methylation patterns and miRNA expression profile as well as histone modifications are all capable of inducing an altered gene expression profile involved in various cellular cascades including cell cycle, proliferation and apoptosis. In general, there is an interest about the beneficiary effect of various phytochemicals in the prevention and treatment of skin malignancies. Among them, glucosinolates are an important type of compounds, abundant in cruciferous vegetables, which are hydrolysed by an endogenous enzyme called myrosinase to a range of bioactive compounds including isothiocyanates (ITCs). These are the major biologically active products capable of mediating the anti-cancer effect of cruciferous vegetables. Their chemo-preventive action is mainly attributed to a plurality of anti-cancer properties including regulation of the epigenetic machinery. Current evidence supports the view that ITCs are potent compounds in interacting with the epigenome in order to restore the normal epigenetic landscape in malignant cells. This review article summarizes the current state of knowledge on the epigenetic modifications that lead to malignant transformation and the role of ITCs with respect to their ability to restore the epigenetic landscape that contributes to skin carcinogenesis.",
keywords = "Basal cell carcinoma, Chemoprevention, Epigenetic regulation, Isothiocyanates, Melanoma, Non-melanoma skin cancer, Skin cancer, Squamous cell carcinoma, Sulforaphane",
author = "Melina Mitsiogianni and Tom Amery and Rodrigo Franco-Cruz and Vasilis Zoumpourlis and Aglaia Pappa and Panayiotidis, {Mihalis I.}",
year = "2018",
month = "10",
doi = "10.1016/j.pharmthera.2018.06.001",
language = "English (US)",
volume = "190",
pages = "187--201",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - From chemo-prevention to epigenetic regulation

T2 - The role of isothiocyanates in skin cancer prevention

AU - Mitsiogianni, Melina

AU - Amery, Tom

AU - Franco-Cruz, Rodrigo

AU - Zoumpourlis, Vasilis

AU - Pappa, Aglaia

AU - Panayiotidis, Mihalis I.

PY - 2018/10

Y1 - 2018/10

N2 - Skin cancer incidence is rapidly growing over the last decades and is generally divided into malignant melanoma and non-melanoma (NMSC) with the latter being subdivided into squamous (SCC) and basal cell carcinoma (BCC). Among them, melanoma is the most aggressive type with high mortality rates. On the other hand, aberrant gene expression is a critical step towards malignant transformation. To this end, epigenetic modifications like changes in DNA methylation patterns and miRNA expression profile as well as histone modifications are all capable of inducing an altered gene expression profile involved in various cellular cascades including cell cycle, proliferation and apoptosis. In general, there is an interest about the beneficiary effect of various phytochemicals in the prevention and treatment of skin malignancies. Among them, glucosinolates are an important type of compounds, abundant in cruciferous vegetables, which are hydrolysed by an endogenous enzyme called myrosinase to a range of bioactive compounds including isothiocyanates (ITCs). These are the major biologically active products capable of mediating the anti-cancer effect of cruciferous vegetables. Their chemo-preventive action is mainly attributed to a plurality of anti-cancer properties including regulation of the epigenetic machinery. Current evidence supports the view that ITCs are potent compounds in interacting with the epigenome in order to restore the normal epigenetic landscape in malignant cells. This review article summarizes the current state of knowledge on the epigenetic modifications that lead to malignant transformation and the role of ITCs with respect to their ability to restore the epigenetic landscape that contributes to skin carcinogenesis.

AB - Skin cancer incidence is rapidly growing over the last decades and is generally divided into malignant melanoma and non-melanoma (NMSC) with the latter being subdivided into squamous (SCC) and basal cell carcinoma (BCC). Among them, melanoma is the most aggressive type with high mortality rates. On the other hand, aberrant gene expression is a critical step towards malignant transformation. To this end, epigenetic modifications like changes in DNA methylation patterns and miRNA expression profile as well as histone modifications are all capable of inducing an altered gene expression profile involved in various cellular cascades including cell cycle, proliferation and apoptosis. In general, there is an interest about the beneficiary effect of various phytochemicals in the prevention and treatment of skin malignancies. Among them, glucosinolates are an important type of compounds, abundant in cruciferous vegetables, which are hydrolysed by an endogenous enzyme called myrosinase to a range of bioactive compounds including isothiocyanates (ITCs). These are the major biologically active products capable of mediating the anti-cancer effect of cruciferous vegetables. Their chemo-preventive action is mainly attributed to a plurality of anti-cancer properties including regulation of the epigenetic machinery. Current evidence supports the view that ITCs are potent compounds in interacting with the epigenome in order to restore the normal epigenetic landscape in malignant cells. This review article summarizes the current state of knowledge on the epigenetic modifications that lead to malignant transformation and the role of ITCs with respect to their ability to restore the epigenetic landscape that contributes to skin carcinogenesis.

KW - Basal cell carcinoma

KW - Chemoprevention

KW - Epigenetic regulation

KW - Isothiocyanates

KW - Melanoma

KW - Non-melanoma skin cancer

KW - Skin cancer

KW - Squamous cell carcinoma

KW - Sulforaphane

UR - http://www.scopus.com/inward/record.url?scp=85048352079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048352079&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2018.06.001

DO - 10.1016/j.pharmthera.2018.06.001

M3 - Review article

C2 - 29890115

AN - SCOPUS:85048352079

VL - 190

SP - 187

EP - 201

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

ER -